Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Harvoni in Pediatric HCV Patients on Chemotherapy
NCT02868242Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Aug 2016
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ledipasvir in hepatitis C (HCV), sponsored by Gilead Sciences. Started Aug 2016; status: completed.
02
Drugs
ledipasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02868242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02868242.